This is a Validated Antibody Database (VAD) review about human CALML3, based on 5 published articles (read how Labome selects the articles), using CALML3 antibody in all methods. It is aimed to help Labome visitors find the most suited CALML3 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CALML3 synonym: CLP; calmodulin-like protein 3; caM-like protein; calmodulin-related protein NB-1
Santa Cruz Biotechnology
mouse monoclonal (G-3) |
| Santa Cruz Biotechnology CALML3 antibody (Santa Cruz, sc-137079) was used in western blot on rat samples at 1:1000 (fig 3). Exp Ther Med (2016) ncbi |
mouse monoclonal (G-3) |
| Santa Cruz Biotechnology CALML3 antibody (Santa Cruz Biotechnology, sc-137079) was used in western blot on rat samples at 1:1000 (fig s4). Nat Commun (2016) ncbi |
mouse monoclonal (G-3) |
| Santa Cruz Biotechnology CALML3 antibody (santa Cruz, sc-137079) was used in western blot on rat samples at 1:800 (fig 2). Mol Med Rep (2015) ncbi |
mouse monoclonal (G-3) |
| Santa Cruz Biotechnology CALML3 antibody (Santa Cruz Biotechnology, sc-137079) was used in western blot on mouse samples (fig 3). J Biol Chem (2015) ncbi |
mouse monoclonal (G-3) |
| In order to identify the molecular mechanisms that regulate the enrichment of KCNQ channels at the neuronal axon, Santa Cruz Biotechnology CALML3 antibody (Santa Cruz, SC137079) was used in western blot on rat samples at 1:200. PLoS ONE (2014) ncbi |
Articles Reviewed
- Zhang Y, Lin R, Tao J, Wu Y, Chen B, Yu K, et al. Electroacupuncture improves cognitive ability following cerebral ischemia reperfusion injury via CaM-CaMKIV-CREB signaling in the rat hippocampus. Exp Ther Med. 2016;12:777-782 pubmed
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
related gene review
questions and comments